Health Ingredients Europe Sneak Peek: Staving Off Postprandial Blood Glucose Spikes

October 26, 2012

Clinical trials show that consumption of Cavamax W6 can contribute to the reduction of the blood glucose rise that occurs after starch-containing meals.

Wacker offers a soluble dietary fiber that is scientifically proven and acknowledged by EFSA to have a significant effect on reducing postprandial glycaemic response. This fiber, branded under the trademark Cavamax W6, is an alpha-cyclodextrin, a carbohydrate enzymatically derived from starch. Clinical trials show that consumption of Cavamax W6 can contribute to the reduction of the blood glucose rise that occurs after starch-containing meals. Further clinical trials show a positive effect of Cavamax W6 on blood lipid levels. Cavamax W6 is highly stable in heat and acidic conditions, is non-hygroscopic and non-browning, and is ideally suited for beverage applications.

Wacker Chemie AG

Booth C46